Drug Shortage Report for MULTI 12 INJECTION
Report ID | 189909 |
Drug Identification Number | 02100606 |
Brand name | MULTI 12 INJECTION |
Common or Proper name | MULTI 12 INJECTION |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VITAMIN B12 FOLIC ACID BIOTIN VITAMIN E DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN B2 VITAMIN B1 VITAMIN D VITAMIN A ASCORBIC ACID |
Strength(s) | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ML |
ATC code | B05XC |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-20 |
Estimated end date | 2023-06-16 |
Actual end date | 2023-05-01 |
Shortage status | Resolved |
Updated date | 2023-05-03 |
Company comments | Baxter item: 6410 This product is under allocation with 75% allocated. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-05-03 | English | Compare |
v6 | 2023-05-01 | French | Compare |
v5 | 2023-05-01 | English | Compare |
v4 | 2023-04-21 | English | Compare |
v3 | 2023-04-20 | French | Compare |
v2 | 2023-04-20 | French | Compare |
v1 | 2023-04-20 | English | Compare |
Showing 1 to 7 of 7